NLS Denmark

The research-based company Bioneer now offers industry collaboration in drug development by using the gene editing technology CRISPR combined with induced pluripotent stem cells. The CRISPR technology (Clustered Regularly Interspaced Short Palindromic Repeats) is currently the hottest gene editing technology in use. It allows scientists to edit genomes with unprecedented precision, efficiency, and flexibility. Hence, […]

Industry-leaders get where they are by capitalizing on their strengths, whether that is an educated workforce, innovative thinkers, strong public-private partnerships or efficient government. With all these assets plus more, it is no surprise that Denmark has emerged as a world leader in the life sciences and health care. Thanks to world-class research facilities and […]

Forbes Magazine ranks Denmark no. 1 in their global league table “Best Countries for Business”. Just recently, the World Bank ranked Denmark first in Europe in their Doing Business Report, and the Danish Minister for Foreign Affairs, Kristian Jensen, hopes that the recurring international recognition of the Danish business climate will attract more foreign investors:“Creating […]

The university of Copenhagen is planning the construction of the new Niels Bohr Science Park (NBSP). The new Science park will help to ensure Denmark a framework for world-class scientific research and education. The new buildings under the name of Niels Bohr Science Park (NBSP) will bring together science, physics, chemistry, mathematics, computer science and science […]

Novo Nordisk invests DKK 2.1 billion in new insulin filling facility in Denmark, creating 450 new jobs. The company is investing 2.1 billion Danish kroner in a new 10,300 m2 facility in Hillerød, Denmark. The facility will produce medicines for the treatment of diabetes and obesity. A groundbreaking ceremony marking the start of construction was held on […]

The Novo Nordisk Foundation and the Capital Region of Denmark has plans to establish a new major diabetes centre in Copenhagen as a result of the foundation’s €375 million grant. The new “Steno Diabetes Center Copenhagen” will serve as a driving force for world-class treatment and clinical research within diabetes. Furthermore, it will act as […]